Neural effects of a single dose of fluoxetine on resting-state functional connectivity in adolescent depression
- PMID: 33143532
- PMCID: PMC7708665
- DOI: 10.1177/0269881120959608
Neural effects of a single dose of fluoxetine on resting-state functional connectivity in adolescent depression
Abstract
Fluoxetine is commonly prescribed in adolescent depression, but the neural mechanisms underlying its action remain poorly understood. Here, we used resting-state functional magnetic resonance imaging to investigate the effects of a single dose of fluoxetine vs. placebo in adolescents with major depressive disorder. In contrast with previous studies in adults that have demonstrated an acute effect of antidepressants on activity within the default mode network, a single dose of fluoxetine did not alter activity in this network in adolescent depression. There were unexpected group activity differences in the motor network, which should be clarified in future research.
Keywords: Fluoxetine; adolescent depression; resting-state functional connectivity.
Conflict of interest statement
Figures


Similar articles
-
Eight-week antidepressant treatment reduces functional connectivity in first-episode drug-naïve patients with major depressive disorder.Hum Brain Mapp. 2021 Jun 1;42(8):2593-2605. doi: 10.1002/hbm.25391. Epub 2021 Feb 27. Hum Brain Mapp. 2021. PMID: 33638263 Free PMC article. Clinical Trial.
-
The alteration of cognitive function networks in remitted patients with major depressive disorder: an independent component analysis.Behav Brain Res. 2021 Feb 26;400:113018. doi: 10.1016/j.bbr.2020.113018. Epub 2020 Dec 7. Behav Brain Res. 2021. PMID: 33301816
-
A proof-of-concept study comparing tinnitus and neural connectivity changes following multisensory perceptual training with and without a low-dose of fluoxetine.Int J Neurosci. 2021 May;131(5):433-444. doi: 10.1080/00207454.2020.1746310. Epub 2020 Apr 13. Int J Neurosci. 2021. PMID: 32281466 Clinical Trial.
-
Graph theory approach for the structural-functional brain connectome of depression.Prog Neuropsychopharmacol Biol Psychiatry. 2021 Dec 20;111:110401. doi: 10.1016/j.pnpbp.2021.110401. Epub 2021 Jul 12. Prog Neuropsychopharmacol Biol Psychiatry. 2021. PMID: 34265367 Review.
-
[Fluoxetine: an update of its use in major depressive disorder in adults].Encephale. 2004 Jul-Aug;30(4):392-9. doi: 10.1016/s0013-7006(04)95453-x. Encephale. 2004. PMID: 15597466 Review. French.
Cited by
-
Neuroimaging as a Tool for Advancing Pediatric Psychopharmacology.Paediatr Drugs. 2025 May;27(3):307-330. doi: 10.1007/s40272-025-00683-9. Epub 2025 Feb 3. Paediatr Drugs. 2025. PMID: 39899194 Review.
References
-
- Kaufman J, Birmaher B, Brent D, et al. (1997) Schedule for affective disorders and schizophrenia for school-age children-present and lifetime version (K-SADS-PL): Initial reliability and validity data. J Am Acad Child Adolesc Psychiatry 36: 980–988. Available at: https://www.ncbi.nlm.nih.gov/pubmed/9204677 (accessed 3 February 2020). - PubMed
-
- Loubinoux I, Boulanouar K, Ranjeva JP, et al. (1999) Cerebral functional magnetic resonance imaging activation modulated by a single dose of the monoamine neurotransmission enhancers fluoxetine and fenozolone during hand sensorimotor tasks. J Cereb Blood Flow Metab 19: 1365–1375. 10.1097/00004647-199912000-00010 - DOI - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources